To evaluate trends in botulinum toxin (BTX) industry payments to physicians. Cross-sectional analysis of nonroyalty, BTX-specific payments made by Allergan (Botox), Ipsen (Dysport), and Merz (Xeomin) to physicians using the 2016-2020 Open Payments Database. Between 2016 and 2020, >$27 million in payments was made for BTX-related activities to dermatologists, neurologists, ophthalmologists, otolaryngologists, and plastic surgeons, with payments ranging from $3.9 million in 2016 to $8.7 million in 2019. 21.7% was paid to dermatologists, 57.5% to neurologists, 5.9% to ophthalmologists, 5.7% to otolaryngologists, and 9.1% to plastic surgeons. Growing amounts are being paid to physicians for BTX-related activities-both medical and aesthetic. Despite the variety of indications for BTX within otolaryngology, otolaryngology payments were overshadowed by other specialties, which may reflect greater BTX utilization in those specialties.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1089/fpsam.2023.0198 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Intragastric botulinum toxin injection for weight loss: current trends, shortcomings and future perspective.
Clin Endosc
November 2024
Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
The administration of botulinum toxin A (BTA) into the gastric wall has emerged as a novel endoscopic bariatric procedure. Although over 20 years have elapsed since the initial human trial of intragastric BTA injection, considerable debate remains surrounding the safety, efficacy, and procedural instructions of this approach. The current literature exhibits discrepancies in the methodologies employed across studies, including differences in the dosage of BTA administered, injection site, number and depth of injections, post-procedural dietary modifications, and follow-up duration.
View Article and Find Full Text PDFBibliometric analysis of research developments in oral and maxillofacial neuralgia from 2004 to 2023.
Medicine (Baltimore)
December 2024
College & Hospital of Stomatology, Anhui Medical University, Key Lab. of Oral Diseases Research of Anhui Province, Hefei, China.
This study employs bibliometric techniques to dynamically represent the research landscape of oral and maxillofacial neuralgia. Its goal is to pinpoint research hotspots and delineate forthcoming trends. A systematic search of the Web of Science Core Collection was performed using targeted keywords to retrieve literature from January 2004 to December 2023.
View Article and Find Full Text PDFThe Efficacy of Botulinum Toxin Use in Service Members and Veterans with Migraine and Post-Traumatic Headache Disorders: A Scoping Review.
J Pain Res
December 2024
Department of Anesthesiology, Perioperative, and Pain Medicine, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA.
Article Synopsis
- The study focuses on the use of botulinum toxin, particularly onabotulinum toxin A (OTA), for treating migraine and post-traumatic headache (PTH) in military personnel and veterans.
- The unique challenges faced by this population, including increased pain intensity and longer headache durations due to combat-related trauma, highlight the need for effective headache management strategies.
- The literature review identified 8 relevant studies, mainly from the U.S., indicating that chronic migraine is the most common diagnosis treated with botulinum toxin, suggesting its effectiveness for preventing such conditions in service members.
2021 trends in the treatment of patients with strabismus in Japan.
Jpn J Ophthalmol
December 2024
Department of Ophthalmology, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashi-ku, Hamamatsu-City, Shizuoka, 431-3192, Japan.
Purpose: To clarify the actual status of strabismus surgery and botulinum toxin (BTX) therapy in Japan in the year 2021.
Study Design: Cross-sectional study.
Methods: We conducted a national survey of strabismus treatment in 2021 using a questionnaire consistent with a previous 2013 survey, incorporating additional questions about BTX therapy.
The synergistic effect of combining botulinum toxin with polydioxanone threads on the upper face static wrinkles.
Arch Dermatol Res
December 2024
Dermatology, Venereology and Andrology Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt.
With aging, facial lines on the forehead and glabella are sometimes converted from dynamic to static giving an aged appearance. Polydioxanone sutures are popular now as a management option in correcting deep static wrinkles on the upper face .This work was conducted to assess the synergistic efficacy of combining Botulinum toxin injection with Polydioxanone threads on the upper face static wrinkles.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!